155 related articles for article (PubMed ID: 23784455)
1. Extension of microRNA expression pattern associated with high-risk neuroblastoma.
Bienertova-Vasku J; Mazanek P; Hezova R; Curdova A; Nekvindova J; Kren L; Sterba J; Slaby O
Tumour Biol; 2013 Aug; 34(4):2315-9. PubMed ID: 23784455
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA profiles in neuroblastoma: Differences in risk and histology groups.
Ergin K; Aktaş S; Altun Z; Dınız G; Olgun N
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e374-e379. PubMed ID: 29115037
[TBL] [Abstract][Full Text] [Related]
3. Next generation sequencing of microRNAs from isogenic neuroblastoma cell lines isolated before and after treatment.
Roth SA; Knutsen E; Fiskaa T; Utnes P; Bhavsar S; Hald ØH; Løkke C; Mestdagh P; Johansen SD; Flægstad T; Einvik C
Cancer Lett; 2016 Mar; 372(1):128-36. PubMed ID: 26708804
[TBL] [Abstract][Full Text] [Related]
4. A review of DNA microarray analysis of human neuroblastomas.
Ohira M; Oba S; Nakamura Y; Hirata T; Ishii S; Nakagawara A
Cancer Lett; 2005 Oct; 228(1-2):5-11. PubMed ID: 15936139
[TBL] [Abstract][Full Text] [Related]
5. Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy.
Challagundla KB; Wise PM; Neviani P; Chava H; Murtadha M; Xu T; Kennedy R; Ivan C; Zhang X; Vannini I; Fanini F; Amadori D; Calin GA; Hadjidaniel M; Shimada H; Jong A; Seeger RC; Asgharzadeh S; Goldkorn A; Fabbri M
J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25972604
[TBL] [Abstract][Full Text] [Related]
6. MYCN controls an alternative RNA splicing program in high-risk metastatic neuroblastoma.
Zhang S; Wei JS; Li SQ; Badgett TC; Song YK; Agarwal S; Coarfa C; Tolman C; Hurd L; Liao H; He J; Wen X; Liu Z; Thiele CJ; Westermann F; Asgharzadeh S; Seeger RC; Maris JM; Guidry Auvil JM; Smith MA; Kolaczyk ED; Shohet J; Khan J
Cancer Lett; 2016 Feb; 371(2):214-24. PubMed ID: 26683771
[TBL] [Abstract][Full Text] [Related]
7. A novel risk signature that combines 10 long noncoding RNAs to predict neuroblastoma prognosis.
Gao L; Lin P; Chen P; Gao RZ; Yang H; He Y; Chen JB; Luo YG; Xu QQ; Liang SW; Gu JH; Huang ZG; Dang YW; Chen G
J Cell Physiol; 2020 Apr; 235(4):3823-3834. PubMed ID: 31612488
[TBL] [Abstract][Full Text] [Related]
8. Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma.
Wen W; Mai SJ; Lin HX; Zhang MY; Huang JL; Hua X; Lin C; Long ZQ; Lu ZJ; Sun XQ; Liu SL; Yang Q; Zhu Q; Wang HY; Guo L
J Transl Med; 2019 Jun; 17(1):186. PubMed ID: 31159814
[TBL] [Abstract][Full Text] [Related]
9. The roles of microRNAs in neuroblastoma.
Mei H; Lin ZY; Tong QS
World J Pediatr; 2014 Feb; 10(1):10-6. PubMed ID: 24464658
[TBL] [Abstract][Full Text] [Related]
10. Expression of NLRR3 orphan receptor gene is negatively regulated by MYCN and Miz-1, and its downregulation is associated with unfavorable outcome in neuroblastoma.
Akter J; Takatori A; Hossain MS; Ozaki T; Nakazawa A; Ohira M; Suenaga Y; Nakagawara A
Clin Cancer Res; 2011 Nov; 17(21):6681-92. PubMed ID: 21908575
[TBL] [Abstract][Full Text] [Related]
11. Expression profiling and characterization of 4200 genes cloned from primary neuroblastomas: identification of 305 genes differentially expressed between favorable and unfavorable subsets.
Ohira M; Morohashi A; Inuzuka H; Shishikura T; Kawamoto T; Kageyama H; Nakamura Y; Isogai E; Takayasu H; Sakiyama S; Suzuki Y; Sugano S; Goto T; Sato S; Nakagawara A
Oncogene; 2003 Aug; 22(35):5525-36. PubMed ID: 12934113
[TBL] [Abstract][Full Text] [Related]
12. Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma.
Gattolliat CH; Thomas L; Ciafrè SA; Meurice G; Le Teuff G; Job B; Richon C; Combaret V; Dessen P; Valteau-Couanet D; May E; Busson P; Douc-Rasy S; Bénard J
Br J Cancer; 2011 Oct; 105(9):1352-61. PubMed ID: 21970883
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis.
Liu N; Chen NY; Cui RX; Li WF; Li Y; Wei RR; Zhang MY; Sun Y; Huang BJ; Chen M; He QM; Jiang N; Chen L; Cho WC; Yun JP; Zeng J; Liu LZ; Li L; Guo Y; Wang HY; Ma J
Lancet Oncol; 2012 Jun; 13(6):633-41. PubMed ID: 22560814
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs in neuroblastoma: small-sized players with a large impact.
Zhi F; Wang R; Wang Q; Xue L; Deng D; Wang S; Yang Y
Neurochem Res; 2014 Apr; 39(4):613-23. PubMed ID: 24477657
[TBL] [Abstract][Full Text] [Related]
15. A sketch of known and novel MYCN-associated miRNA networks in neuroblastoma.
Megiorni F; Colaiacovo M; Cialfi S; McDowell HP; Guffanti A; Camero S; Felsani A; Losty PD; Pizer B; Shukla R; Cappelli C; Ferrara E; Pizzuti A; Moles A; Dominici C
Oncol Rep; 2017 Jul; 38(1):3-20. PubMed ID: 28586032
[TBL] [Abstract][Full Text] [Related]
16. microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma.
Lin RJ; Lin YC; Chen J; Kuo HH; Chen YY; Diccianni MB; London WB; Chang CH; Yu AL
Cancer Res; 2010 Oct; 70(20):7841-50. PubMed ID: 20805302
[TBL] [Abstract][Full Text] [Related]
17. miRNA expression profiling of the murine TH-MYCN neuroblastoma model reveals similarities with human tumors and identifies novel candidate miRNAs.
Terrile M; Bryan K; Vaughan L; Hallsworth A; Webber H; Chesler L; Stallings RL
PLoS One; 2011; 6(12):e28356. PubMed ID: 22164278
[TBL] [Abstract][Full Text] [Related]
18. Molecular Characterization of Renal Cell Carcinoma: A Potential Three-MicroRNA Prognostic Signature.
Lokeshwar SD; Talukder A; Yates TJ; Hennig MJP; Garcia-Roig M; Lahorewala SS; Mullani NN; Klaassen Z; Kava BR; Manoharan M; Soloway MS; Lokeshwar VB
Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):464-472. PubMed ID: 29440068
[No Abstract] [Full Text] [Related]
19. Lack of Thy1 (CD90) expression in neuroblastomas is correlated with impaired survival.
Fiegel HC; Kaifi JT; Quaas A; Varol E; Krickhahn A; Metzger R; Sauter G; Till H; Izbicki JR; Erttmann R; Kluth D
Pediatr Surg Int; 2008 Jan; 24(1):101-5. PubMed ID: 17952444
[TBL] [Abstract][Full Text] [Related]
20. A 4-microRNA signature predicts lymph node metastasis and prognosis in breast cancer.
Chen X; Wang YW; Zhu WJ; Li Y; Liu L; Yin G; Gao P
Hum Pathol; 2018 Jun; 76():122-132. PubMed ID: 29555574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
